CDK5 and neoplasm: The absence of Cdk5 induces the expression of PD-L1 transcriptional inhibitors (IRF2 and IRF2BP2), maintaining transcriptional repression of PD-L1 after IFN-γ stimulation, resulting in increased infiltration of CD4 T cells and promoting anti-tumor immune responses [211].